GlassScriptPhysician profile
Neel B Vaidya
NPI 1285098541
$156,257.79
in general payments reported to CMS, 2019-2025
26 companies · $83K in 2025
The $83K reported for 2025 was more than what 99% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $373 · 2020: $36.35 · 2021: $933 · 2022: $5,602 · 2023: $12K · 2024: $54K · 2025: $83K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $81K · Consulting Fee: $40K · Travel and Lodging: $12K · Food and Beverage: $12K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,850 · Honoraria: $38.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $81,425.00 |
| Consulting Fee | $40,141.91 |
| Travel and Lodging | $12,024.16 |
| Food and Beverage | $11,833.83 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,850.00 |
| Honoraria | $38.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $90,416.73 | 2023-2025 | Miebo, Xiidra, Envista Mx60 Iol |
| Rxsight INC | $15,320.49 | 2023-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Dompe US, INC. | $10,493.13 | 2019-2025 | Oxervate |
| Carl Zeiss Meditec, INC. | $10,107.78 | 2022-2025 | Artevo 800, Forum, Visumax |
| Alcon Vision LLC | $8,315.80 | 2019-2025 | Unity, Centurion, Clareon |
| Abbvie INC. | $7,430.22 | 2023-2025 | Durysta |
| Glaukos Corporation | $6,119.13 | 2021-2025 | Epioxa, Travoprost Intraocular Implant - Idose, Photrexa Viscous and Photrexa |
| Carl Zeiss Meditec USA, INC. | $4,178.47 | 2021-2025 | Mel 90, Visumax, Cirrus Hd-Oct |
| Sun Pharmaceutical Industries INC. | $1,425.27 | 2022-2025 | Cequa, Xelpros, Bromsite |
| Novartis Pharmaceuticals Corporation | $675.88 | 2020-2023 | |
| Oyster Point Pharma, INC. | $296.66 | 2022-2024 | Tyrvaya, Ryzumvi |
| Biotissue Holdings INC. | $290.25 | 2021-2025 | |
| Tarsus Pharmaceuticals, INC. | $269.47 | 2024-2025 | Xdemvy |
| Harrow Eye, LLC | $253.21 | 2023-2025 | Iheezo, Vevye |
| Amgen INC. | $154.43 | 2024-2025 | Tepezza |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $142.92 | 2022-2025 | Acthar |
| Novo Nordisk INC | $111.77 | 2025 | Ozempic |
| Horizon Therapeutics Plc | $46.70 | 2022 | |
| Lensar, INC. | $46.50 | 2023-2025 | Lensar Laser System |
| Kala Pharmaceuticals, INC. | $38.58 | 2020-2021 | |
| Eyevance Pharmaceuticals LLC | $30.97 | 2021 | |
| Beaver-Visitec International, INC. | $24.63 | 2023 | |
| Sight Sciences, INC. | $23.23 | 2022 | |
| Aerie Pharmaceuticals, INC. | $21.11 | 2021 | |
| Allergan, INC. | $13.90 | 2021 | |
| New World Medical,INC. | $10.56 | 2024 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neel Vaidya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.